Cellcept 200 mg

CELLCEPT 200 MG is a powder for suspension used for immunosuppression. It contains mycophenolate mofetil, a medication that helps prevent organ rejection. This product is manufactured by Hoffmann-La Roche Limited in Canada.

CELLCEPT 200 MG is primarily used to prevent organ rejection in patients who have received a kidney, heart, or liver transplant. It works by suppressing the immune system to reduce the risk of the body rejecting the transplanted organ. This medication is often prescribed as part of a broader treatment plan that may include other immunosuppressants.

Common effects of CELLCEPT 200 MG may include gastrointestinal issues such as nausea, vomiting, and diarrhea. Some users may also experience fatigue, headache, or an increased risk of infections due to the suppression of the immune system. It is important to monitor for any signs of infection or other adverse reactions while taking this medication.

CELLCEPT 200 MG should be handled with care, as it can be harmful if inhaled or if it comes into contact with the skin or eyes. It is important to follow the preparation instructions carefully to ensure the correct dosage is administered. Patients should also be aware of the increased risk of infections and other side effects associated with immunosuppression.

CELLCEPT 200 MG may interact with other medications, including those that affect the immune system or metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication, so it is advisable to discuss any dietary or lifestyle changes with a healthcare professional.